187 related articles for article (PubMed ID: 29202482)
1. Ligand-activated BMP signaling inhibits cell differentiation and death to promote melanoma.
Venkatesan AM; Vyas R; Gramann AK; Dresser K; Gujja S; Bhatnagar S; Chhangawala S; Gomes CBF; Xi HS; Lian CG; Houvras Y; Edwards YJK; Deng A; Green M; Ceol CJ
J Clin Invest; 2018 Jan; 128(1):294-308. PubMed ID: 29202482
[TBL] [Abstract][Full Text] [Related]
2. Regulation of zebrafish melanocyte development by ligand-dependent BMP signaling.
Gramann AK; Venkatesan AM; Guerin M; Ceol CJ
Elife; 2019 Dec; 8():. PubMed ID: 31868592
[TBL] [Abstract][Full Text] [Related]
3. Ror2 signaling is required for local upregulation of GDF6 and activation of BMP signaling at the neural plate border.
Schille C; Bayerlová M; Bleckmann A; Schambony A
Development; 2016 Sep; 143(17):3182-94. PubMed ID: 27578181
[TBL] [Abstract][Full Text] [Related]
4. A New Subtype of Multiple Synostoses Syndrome Is Caused by a Mutation in GDF6 That Decreases Its Sensitivity to Noggin and Enhances Its Potency as a BMP Signal.
Wang J; Yu T; Wang Z; Ohte S; Yao RE; Zheng Z; Geng J; Cai H; Ge Y; Li Y; Xu Y; Zhang Q; Gusella JF; Fu Q; Pregizer S; Rosen V; Shen Y
J Bone Miner Res; 2016 Apr; 31(4):882-9. PubMed ID: 26643732
[TBL] [Abstract][Full Text] [Related]
5. The BMP ligand Gdf6 prevents differentiation of coronal suture mesenchyme in early cranial development.
Clendenning DE; Mortlock DP
PLoS One; 2012; 7(5):e36789. PubMed ID: 22693558
[TBL] [Abstract][Full Text] [Related]
6. Defective Joint Development and Maintenance in GDF6-Related Multiple Synostoses Syndrome.
Yu T; Li G; Wang C; Li N; Yao R; Wang J
J Bone Miner Res; 2023 Apr; 38(4):568-577. PubMed ID: 36744814
[TBL] [Abstract][Full Text] [Related]
7. [Malignant melanoma and the role of the paradoxal protein Microphthalmia transcription factor].
Denat L; Larue L
Bull Cancer; 2007 Jan; 94(1):81-92. PubMed ID: 17237008
[TBL] [Abstract][Full Text] [Related]
8. Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas.
Giuliano S; Cheli Y; Ohanna M; Bonet C; Beuret L; Bille K; Loubat A; Hofman V; Hofman P; Ponzio G; Bahadoran P; Ballotti R; Bertolotto C
Cancer Res; 2010 May; 70(9):3813-22. PubMed ID: 20388797
[TBL] [Abstract][Full Text] [Related]
9. Rare heterozygous GDF6 variants in patients with renal anomalies.
Martens H; Hennies I; Getwan M; Christians A; Weiss AC; Brand F; Gjerstad AC; Christians A; Gucev Z; Geffers R; Seeman T; Kispert A; Tasic V; Bjerre A; Lienkamp SS; Haffner D; Weber RG
Eur J Hum Genet; 2020 Dec; 28(12):1681-1693. PubMed ID: 32737436
[TBL] [Abstract][Full Text] [Related]
10. A novel stilbene-like compound that inhibits melanoma growth by regulating melanocyte differentiation and proliferation.
Stueven NA; Schlaeger NM; Monte AP; Hwang SL; Huang CC
Toxicol Appl Pharmacol; 2017 Dec; 337():30-38. PubMed ID: 29042215
[TBL] [Abstract][Full Text] [Related]
11. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness.
Carreira S; Goodall J; Denat L; Rodriguez M; Nuciforo P; Hoek KS; Testori A; Larue L; Goding CR
Genes Dev; 2006 Dec; 20(24):3426-39. PubMed ID: 17182868
[TBL] [Abstract][Full Text] [Related]
12. Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cells.
Pathria G; Garg B; Borgdorff V; Garg K; Wagner C; Superti-Furga G; Wagner SN
Cell Death Dis; 2016 Mar; 7(3):e2135. PubMed ID: 26962685
[TBL] [Abstract][Full Text] [Related]
13. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S
Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878
[TBL] [Abstract][Full Text] [Related]
14. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.
Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A
Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332
[TBL] [Abstract][Full Text] [Related]
15. Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells.
Goodall J; Carreira S; Denat L; Kobi D; Davidson I; Nuciforo P; Sturm RA; Larue L; Goding CR
Cancer Res; 2008 Oct; 68(19):7788-94. PubMed ID: 18829533
[TBL] [Abstract][Full Text] [Related]
16. NRG1 / ERBB3 signaling in melanocyte development and melanoma: inhibition of differentiation and promotion of proliferation.
Buac K; Xu M; Cronin J; Weeraratna AT; Hewitt SM; Pavan WJ
Pigment Cell Melanoma Res; 2009 Dec; 22(6):773-84. PubMed ID: 19659570
[TBL] [Abstract][Full Text] [Related]
17. MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.
Du J; Miller AJ; Widlund HR; Horstmann MA; Ramaswamy S; Fisher DE
Am J Pathol; 2003 Jul; 163(1):333-43. PubMed ID: 12819038
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
19. PRL3-DDX21 Transcriptional Control of Endolysosomal Genes Restricts Melanocyte Stem Cell Differentiation.
Johansson JA; Marie KL; Lu Y; Brombin A; Santoriello C; Zeng Z; Zich J; Gautier P; von Kriegsheim A; Brunsdon H; Wheeler AP; Dreger M; Houston DR; Dooley CM; Sims AH; Busch-Nentwich EM; Zon LI; Illingworth RS; Patton EE
Dev Cell; 2020 Aug; 54(3):317-332.e9. PubMed ID: 32652076
[TBL] [Abstract][Full Text] [Related]
20. Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas.
Dynek JN; Chan SM; Liu J; Zha J; Fairbrother WJ; Vucic D
Cancer Res; 2008 May; 68(9):3124-32. PubMed ID: 18451137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
